Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Sildenafil in Eisenmenger Physiology
2006-004705-26Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sildenafil in Eisenmenger syndrome, sponsored by Imperial College London. Primary endpoint: Systemic oxygen saturation. Started Apr 2007; status: completed.
02
Drugs
sildenafil
03
Conditions
Eisenmenger syndrome
Beyond the preview
Go deeper on 2006-004705-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004705-26.